CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Wedbush Adjusts Price Target on Alto Neuroscience to $26 From $24, Keeps Neutral Rating

Neutral
AI Analysis

Summary

Wedbush raised its price target on Alto Neuroscience from $24 to $26 while maintaining a Neutral rating.

Importance:2/10
Sentiment:
0.10
price_target_adjustmentanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 10:50 AM

Read Original